Skip to main content
SpringerLink
Log in

Candesartan Cilexetil in Children and Adolescents Aged 1 to <17 Years with Hypertension

Profile Report

  • Adis Profile Report
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. Hoy SM, Keating GM. Candesartan cilexetil in children and adolescents aged 1 to <17 years with hypertension. Am J Cardiovasc Drugs 2010 Oct; 10(5): 335–42

    Article  PubMed  CAS  Google Scholar 

  2. Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA 2007 Aug; 298(8): 874–9

    Article  PubMed  CAS  Google Scholar 

  3. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004 Aug; 114 (2 Suppl. 4th Report): 555–76

    Google Scholar 

  4. Lurbe E, Cifkova R, Cruickshank JK, et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 2009 Sep; 27(9): 1719–42

    Article  PubMed  CAS  Google Scholar 

  5. Flynn JT. Pediatric hypertension: recent trends and accomplishments, future challenges. Am J Hypertens 2008 Jun; 21(6): 605–12

    Article  PubMed  Google Scholar 

  6. AstraZeneca. Atacand® (candesartan cilexetil) tablets: prescribing information [online]. Available from URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020838s031lbl.pdf [Accessed 2010 Jul 2]

  7. Schaefer F, Van De Walle J, Zurowska A, et al. Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age. J Hypertens 2010 May; 28(5): 1083–90

    Article  PubMed  CAS  Google Scholar 

  8. Trachtman H, Hainer JW, Sugg J, et al. Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 years. J Clin Hypertens 2008 Oct; 10(10): 743–50

    Article  CAS  Google Scholar 

  9. AstraZeneca. An open-label extension study of candesartan cilexetil in hypertensive pediatric subjects ages 1 to <11 years: a long-term study [online]. Available from URL: http://www.astrazenecaclinicaltrials.com/drug-products/drugproducts/?itemId=8592674 [Accessed 2010 Sep 14]

Download references

Acknowledgments and Disclosures

The full text article[1] from which this profile report was derived was reviewed by: D.C. Kaelber, Case Western Reserve University and the Departments of Internal Medicine, Pediatrics, and Information Service, The MetroHealth System, Cleveland, Ohio, USA; H. Trachtman, Long Island Campus for the Albert Einstein College of Medicine, Department of Pediatrics, Division of Nephrology, Cohen Children’s Medical Center of New York, North Shore-Long Island Jewish Medical Center, New Hyde Park, New York, USA. The manufacturer of the agent under review was offered an opportunity to comment on the original article[1] during the peer review process; changes based on any comments received were made on the basis of scientific and editorial merit. The preparation of the original article and this profile report was not supported by any external funding.

Author information

Authors and Affiliations

  1. Adis, a Wolters Kluwer Business, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore 0754, Auckland, New Zealand

    Sheridan M. Hoy & Gillian M. Keating

Authors
  1. Sheridan M. Hoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gillian M. Keating
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sheridan M. Hoy.

Additional information

Adapted and reproduced from the original article published in American Journal of Cardiovascular Drugs 2010; 10 (5): 335–42.[1]

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoy, S.M., Keating, G.M. Candesartan Cilexetil in Children and Adolescents Aged 1 to <17 Years with Hypertension. Pediatr Drugs 14, 61–62 (2012). https://doi.org/10.2165/11206950-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11206950-000000000-00000

Keywords

Search

Navigation